↓ Skip to main content

Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report

Overview of attention for article published in Journal of Medical Case Reports, April 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report
Published in
Journal of Medical Case Reports, April 2021
DOI 10.1186/s13256-021-02748-y
Pubmed ID
Authors

Caroline Y. Chen, Charlene M. Fares, Daniel Sanghoon Shin

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 25%
Researcher 2 17%
Lecturer 1 8%
Other 1 8%
Student > Postgraduate 1 8%
Other 0 0%
Unknown 4 33%
Readers by discipline Count As %
Medicine and Dentistry 4 33%
Pharmacology, Toxicology and Pharmaceutical Science 2 17%
Business, Management and Accounting 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Unknown 4 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2021.
All research outputs
#13,165,668
of 23,308,124 outputs
Outputs from Journal of Medical Case Reports
#837
of 4,015 outputs
Outputs of similar age
#187,061
of 435,089 outputs
Outputs of similar age from Journal of Medical Case Reports
#36
of 196 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,015 research outputs from this source. They receive a mean Attention Score of 4.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,089 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 196 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.